
Aequs Analyst Review 2027: Aerospace Grows 44% but Consumer Losses Deepen the Q2 Loss
Updated: 18 Nov 2026 • 3:07 pm
Posted by:

Aequs Stock Snapshot (17 Nov 2026 close)
- Current Market Price (CMP): ₹239.43
- 52-Week High / Low: ₹294.70 / ₹113.30
- Market Capitalisation: ₹16,049 crore
- P/E Ratio vs Industry P/E: Not meaningful (loss) vs 47.0
- Latest Quarter (Q2 FY27) Revenue: ₹409.07 crore
- Latest Quarter (Q2 FY27) Net Profit: Loss of ₹52.39 crore
Quick Answer: The Aequs analyst review 2027 finds no verified brokerage target as of November 2026. Q2 FY27 revenue rose about 45.3% to ₹409.07 crore, and the aerospace segment grew about 44% to ₹351.4 crore with an EBITDA margin near 22%. The consumer segment, however, lost ₹40.1 crore at the EBITDA level, and the net loss widened to ₹52.39 crore from ₹20.59 crore. Management pushed consumer break-even beyond Q4 FY27, and the stock fell as much as 19% on 27 October. The Aequs share price target 2027 question turns on how fast those losses shrink.
The Aequs analyst review 2027 covers a Belagavi-based precision manufacturer that makes aircraft components for global planemakers and runs a newer consumer products manufacturing arm. Investors searching for an Aequs share price target 2027 will not find a named brokerage number, so the September quarter and the segment numbers carry most of the weight.
Aequs closed at ₹239.43 on 17 November 2026. That is about 19% below its 52-week high of ₹294.70 and more than double its low of ₹113.30. The company listed in December 2025, so it has less than a year of public results. This Aequs analyst review 2027 explains the split between a growing aerospace business and a loss-making consumer arm, and what that means for the Aequs stock outlook 2027.
Click Here – Get Free Investment Predictions
What Analysts Say in the Aequs Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| No verified coverage | Not available | Not available | As of November 2026 |
We could not verify a current rating or price target from a named brokerage as of November 2026. That is not unusual for a company less than a year after listing, but it means readers have no published benchmark.
The market reaction to Q2 gives the clearest read. The stock fell as much as 19% on 27 October after the results, mainly because the consumer break-even date moved out. Any Aequs share price target 2027 view has to price the two segments separately, which is how this Aequs analyst review 2027 approaches the numbers.
Q2 FY27 Results in the Aequs Analyst Review 2027
| Quarter | Total Income | EBITDA | Net Profit |
|---|---|---|---|
| Sep 2026 (Q2 FY27) | ₹419.69 crore | ₹24.47 crore | Loss of ₹52.39 crore |
| Jun 2026 (Q1 FY27) | ₹402.27 crore | ₹21.48 crore | Loss of ₹53.23 crore |
| Mar 2026 (Q4 FY26) | ₹395.04 crore | ₹32.14 crore | Loss of ₹53.72 crore |
| Dec 2025 (Q3 FY26) | ₹335.23 crore | ₹38.08 crore | Loss of ₹42.68 crore |
| Sep 2025 (Q2 FY26) | ₹297.34 crore | ₹44.25 crore | Loss of ₹20.59 crore |
Revenue from operations rose about 45.3% to ₹409.07 crore. Group EBITDA, however, fell about 45% to about ₹24.5 crore, and the net loss widened to ₹52.39 crore from ₹20.59 crore a year earlier. The loss has stayed near ₹52 crore to ₹54 crore for three quarters, so it is not yet shrinking.
The split explains the gap. Aerospace revenue rose about 44% to ₹351.4 crore and its EBITDA rose about 24% to ₹78.3 crore, a margin near 22%. Consumer revenue rose about 52% to ₹57.7 crore, but its EBITDA loss grew to ₹40.1 crore from ₹7.7 crore. That consumer drag is the main finding of the Aequs analyst review 2027.
How Aequs Makes Money
Aequs runs integrated manufacturing ecosystems, mainly in Belagavi in Karnataka, where machining, forging, surface treatment and assembly sit close together. That set-up is central to every number in the Aequs analyst review 2027.
- Aerospace: precision parts, assemblies and structures for global aircraft makers and their suppliers. This is about 86% of revenue and the profitable side of the business.
- Consumer: contract manufacturing of products such as cookware, toys and consumer electronics parts for global brands. It is growing fast but losing money.
- Order book: the aerospace order book stands near $1.1 billion, which gives revenue visibility for several years.
FY26 revenue from operations was about ₹1,230 crore, up about 33%, and the net loss was ₹113.3 crore. Losses widened from about ₹12 crore in FY24 and ₹102 crore in FY25. Operating cash flow was negative at about ₹99 crore in FY26. For the Aequs analyst review 2027, aerospace growth is not yet enough to cover consumer losses and interest costs.
Growth Triggers in the Aequs Analyst Review 2027
- Aerospace demand: global aircraft makers are raising build rates, and Aequs aerospace revenue grew about 44% in Q2.
- Order visibility: an aerospace order book near $1.1 billion is several times annual aerospace revenue.
- Consumer scale: consumer revenue rose about 52%, and higher volumes should absorb fixed costs over time.
- Supply chain shift: global brands moving production to India add to the customer pipeline.
- Revenue momentum: total income has risen for five straight quarters, which supports the Aequs share price target 2027 case.
Key Risks in the Aequs Analyst Review 2027
- Persistent losses: the quarterly loss has stayed above ₹52 crore for three quarters.
- Consumer delay: break-even in the consumer segment now falls beyond Q4 FY27.
- Negative cash flow: operating cash flow was about minus ₹99 crore in FY26.
- Rich valuation: price to book of about 11.5 for a loss-making company.
- Promoter stake fall: the promoter holding dropped from 64.49% to 59.09% after listing.
- Thin coverage: no named research target in the Aequs analyst review 2027.
Compare Aequs With Other Aerospace and Defence Stocks on the Univest Screener
Aequs Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (17 Nov 2026 close) | ₹239.43 |
| 52-Week High / Low | ₹294.70 / ₹113.30 |
| Market Capitalisation | ₹16,049 crore |
| P/E (TTM) | Not meaningful (loss) |
| Price to Book | 11.52 |
| Book Value per Share | ₹20.77 |
| Return on Equity | Minus 14.5% |
| Debt to Equity | 0.60 |
| EPS (TTM) | Minus ₹3.01 |
| FY26 Revenue / Net Loss | ₹1,230 crore / ₹113.3 crore |
With losses, a P/E ratio does not apply. Price to book value of about 11.5 shows the market is paying for the aerospace order book and future margins. In the Aequs analyst review 2027, that premium depends on the consumer arm reaching break-even.
Shareholding Trend
| Holder | Nov 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 64.49% | 59.09% | Down 5.40 pts |
| Foreign Investors (FII) | 0.00% | 5.93% | Up 5.93 pts |
| Domestic Institutions (DII) | 0.00% | 9.27% | Up 9.27 pts |
| Public | 35.51% | 25.71% | Down 9.80 pts |
The November 2025 figure is the pre-listing pattern. Promoter entities, led by Aequs Manufacturing Investments at 43.35% and the Melligeri Private Family Foundation at 14.99%, now hold 59.09%. Domestic funds hold about 9.3% and foreign funds about 5.9%, which shows institutional interest despite losses. That base is a support point in the Aequs analyst review 2027.
What to Watch After the Aequs Analyst Review 2027
- Consumer EBITDA: whether the ₹40.1 crore Q2 loss starts to narrow.
- Aerospace margin: whether it holds near 22% as volumes rise.
- Net loss trend: a quarter below ₹50 crore would be the first sign of a turn.
- Order book: new aerospace contracts above the $1.1 billion level.
- Research coverage: a first named note would give an Aequs share price target 2027 reference.
Final Word on the Aequs Analyst Review 2027
The Aequs analyst review 2027 shows two businesses moving in opposite directions. Aerospace is growing about 44% with healthy margins and a large order book, while the consumer arm is growing fast but losing more money, keeping the group in the red.
The Aequs stock outlook 2027 depends on narrowing consumer losses, steady aerospace margins and cash flow turning positive. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Aequs analyst review 2027 show?
It shows strong revenue growth but continuing losses. Q2 FY27 revenue rose about 45.3% to ₹409.07 crore. The net loss widened to ₹52.39 crore from ₹20.59 crore. Aerospace grew about 44%, while consumer losses deepened.
Is there an Aequs share price target 2027 from brokerages?
We could not verify a named brokerage target as of November 2026. The stock closed at ₹239.43 on 17 November 2026. It fell as much as 19% on 27 October after the Q2 results.
Why did Aequs post a bigger loss in Q2 FY27?
The consumer segment posted an EBITDA loss of ₹40.1 crore, up from ₹7.7 crore a year earlier. Group EBITDA fell about 45% to about ₹24.5 crore. Management now expects consumer break-even only after Q4 FY27.
How does Aequs make money?
It makes precision aerospace parts and assemblies, which are about 86% of revenue. It also runs a consumer contract manufacturing arm for products such as cookware and toys. FY26 revenue from operations was about ₹1,230 crore.
How large is the Aequs aerospace order book?
The aerospace order book stands near $1.1 billion. Aerospace revenue was ₹351.4 crore in Q2 FY27, up about 44%. Aerospace EBITDA rose about 24% to ₹78.3 crore, a margin near 22%.
What risks does the Aequs analyst review 2027 highlight?
The main risks are persistent losses, negative cash flow and a rich valuation. The quarterly loss has stayed above ₹52 crore for three quarters. Price to book is about 11.5, and FY26 operating cash flow was about minus ₹99 crore.
What should investors track after the Aequs analyst review 2027?
Track whether the consumer EBITDA loss of ₹40.1 crore starts to narrow. Watch whether aerospace margins hold near 22%. A net loss below ₹50 crore in any quarter would be the first sign of a turn.
Recent Articles

Stock Market Today: Share Market Live Updates, Sensex and Nifty 50 Today
18 November 2026

Surana Telecom and Power Share Price Target 2027: 23.8% Upside to Rs 18.6, Bull Rs 22.3
18 November 2026

HDFC Life Insurance Share Price Target 2027: Rs 653 Base, Rs 793 Bull and the Risks to Watch
18 November 2026

Ceinsys Tech Share Price Target 2027: Is Rs 788 Realistic? Bull Case Points to Rs 944
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stock Market Today: Share Market Live Updates, Sensex and Nifty 50 Today
Surana Telecom and Power Share Price Target 2027: 23.8% Upside to Rs 18.6, Bull Rs 22.3
HDFC Life Insurance Share Price Target 2027: Rs 653 Base, Rs 793 Bull and the Risks to Watch
Ceinsys Tech Share Price Target 2027: Is Rs 788 Realistic? Bull Case Points to Rs 944
Bodhi Tree Multimedia Share Price Target 2027: Can It Reach Rs 8.64? Base Case at Rs 7.26

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





